STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
13
Codes C/M, not in net · $564.2K priced
What the filings say about AROW
Insiders, 180 days
-$158.6K net sold
1 seller · 0% of sales under a 10b5-1 plan
Arrow Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ARROW FINANCIAL CORP insiders sold a net $158.6K of stock across 72 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AROW planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Thomas J. Murphy
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.6M
$1.5M
$628.5K
+39%
+53%
2024
$1.2M
$1.2M
$614.2K
+22%
+43%
2022
$1.7M
$1.9M
$584.1K
+28%
+27%
2021
$2.1M
$2.0M
$557.2K
+25%
+37%
2020
$1.7M
$1.4M
$481.4K
-16%
-14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $158.6K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM AROW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM AROW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$44.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM AROW
FY Dec 2025
$36.2M
FY Dec 2024
$28.9M
FY Dec 2023
$13.5M
FY Dec 2022
$45.5M
FY Dec 2021
$61.1M
Jun 2026
$11.6M
Mar 2026
$13.9M
Dec 2025
$4.8M
Sep 2025
$14.3M
Jun 2025
$8.3M
Mar 2025
$8.8M
Dec 2024
$4.1M
Sep 2024
$8.1M
At each fiscal year end
Single quarter
Debt to equity
0.70x
long-term 2025-12-31 (6 months older than the period end) plus current 2026-06-30; equity 2026-06-30
Debt to equity AROW
FY Dec 2025
0.02x
FY Dec 2024
0.04x
FY Dec 2023
0.09x
FY Dec 2022
0.23x
FY Dec 2021
0.12x
Jun 2026
0.70x
Mar 2026
0.02x
Dec 2025
0.02x
Sep 2025
0.03x
Jun 2025
0.04x
Mar 2025
0.04x
Dec 2024
0.04x
Sep 2024
0.08x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.17x
TTM operating cash flow over long-term 2025-12-31 (6 months older than the period end) plus current 2026-06-30
Cash flow to debt AROW
FY Dec 2025
4.84x
FY Dec 2024
2.00x
FY Dec 2023
0.62x
FY Dec 2022
0.72x
FY Dec 2021
1.52x
Jun 2026
0.17x
Mar 2026
5.45x
Dec 2025
4.84x
Sep 2025
3.19x
Jun 2025
2.06x
Mar 2025
1.99x
Dec 2024
2.00x
Sep 2024
0.38x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AROW
FY Dec 2025
+10.6%
FY Dec 2024
+7.6%
FY Dec 2023
+8.2%
FY Dec 2022
+13.5%
FY Dec 2021
+14.1%
Jun 2026
+12.0%
Mar 2026
+12.1%
Dec 2025
+10.6%
Sep 2025
+8.5%
Jun 2025
+7.7%
Mar 2025
+7.2%
Dec 2024
+7.6%
Sep 2024
+8.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AROW
FY Dec 2025
+1.0%
FY Dec 2024
+0.7%
FY Dec 2023
+0.7%
FY Dec 2022
+1.2%
FY Dec 2021
+1.3%
Jun 2026
+1.2%
Mar 2026
+1.1%
Dec 2025
+1.0%
Sep 2025
+0.8%
Jun 2025
+0.7%
Mar 2025
+0.6%
Dec 2024
+0.7%
Sep 2024
+0.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital AROW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed AROW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.40x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing AROW
FY Dec 2025
11.85x
FY Dec 2024
16.22x
FY Dec 2023
15.79x
FY Dec 2022
11.65x
FY Dec 2021
11.52x
Jun 2026
13.22x
Mar 2026
10.86x
Dec 2025
11.85x
Sep 2025
13.67x
Jun 2025
14.44x
Mar 2025
15.46x
Dec 2024
16.22x
Sep 2024
14.62x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$942.3M
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2025-12-31 (6 months older than the period end) plus current 2026-06-30, minus cash 2018-12-31
Enterprise value AROW
FY Dec 2025
$440.6M
FY Dec 2024
$413.5M
FY Dec 2023
$425.3M
FY Dec 2022
$558.7M
FY Dec 2021
$508.8M
Jun 2026
$907.7M
Mar 2026
$478.6M
Dec 2025
$440.6M
Sep 2025
$394.7M
Jun 2025
$373.5M
Mar 2025
$372.5M
Dec 2024
$413.5M
Sep 2024
$428.3M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.3%
TTM free cash flow over market value at close 2026-10-27
FCF yield AROW
FY Dec 2025
+7.0%
FY Dec 2024
+6.0%
FY Dec 2023
+2.8%
FY Dec 2022
+8.1%
FY Dec 2021
+11.1%
Jun 2026
+6.6%
Mar 2026
+7.5%
Dec 2025
+7.0%
Sep 2025
+7.6%
Jun 2025
+6.6%
Mar 2025
+6.5%
Dec 2024
+6.0%
Sep 2024
+1.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.18x
P/E over trailing EPS growth of 69%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing AROW
FY Dec 2025
0.24x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.64x
Jun 2026
0.19x
Mar 2026
0.13x
Dec 2025
0.24x
Sep 2025
2.44x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AROW ranks highest on profitability (62nd percentile) and risk and compliance (41st), and lowest on financial health (20th), among Banks peers.
Profitability
62
Inputs
Return on equity+12.0% · 68 pct, sector of 327
Return on assets+1.2% · 56 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
20
Inputs
Debt to equity0.70x · 17 pct, sector of 229
Cash flow to debt0.17x · 23 pct, sector of 198
Insider conviction
27
Inputs
Net Form 4 buying (codes P and S), 180d-$159K · 54 pct, sector of 273
Insider buyers, 180d0 · 0 pct, sector of 273
Risk and compliance
41
Inputs
Short interest, % of float+3.9% · 41 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Growth, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AROW filings, in plain words
Are Arrow Financial insiders buying or selling AROW?
In the 180 days to 2026-10-28, Arrow Financial insiders were net sellers, a net $158.6K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Arrow Financial insiders were net sellers of AROW, a net $158.6K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.